Company: RCUS
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001724521-25-000063
Chunk: 183

Company: Arcus Biosciences, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part II, Item 2
Chunk 183
---
ification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002    101.INSXBRL Instance Document – The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document    101.SCHInline XBRL Taxonomy Extension Schema Document    101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document    101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document    101.LABInline XBRL Taxonomy Extension Label Linkbase Document    101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document    104Cover Page Interactive Data File (formatted as inline XBRL and contained in exhibit 101)    

_____________________________________

*Filed herewith.

†This certification is deemed furnished but not filed for purposes of section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

AIndicates management contract or compensatory plan or arrangement.

63

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ARCUS BIOSCIENCES, INC.Date:May 6, 2025By:/s/ Terry RosenTerry Rosen, Ph.D.Chief Executive Officer(Principal Executive Officer)Date:May 6, 2025By:/s/ Alexander AzoyAlexander AzoyChief Accounting Officer(Principal Accounting Officer)

64